Search results

68 items matching your search terms.
Filter the results.
Item type

New items since

Sort by relevance · date (newest first) · alphabetically
Carolina Breast Cancer Study enrolls record 3,000 participants
The largest-ever population-based study of breast cancer in North Carolina is poised to begin the five year follow-up phase.
Located in News
UNC researchers create DNA repair map of the entire human genome
The new experimental assay can help scientists find the precise locations of repair of DNA damage caused by UV radiation and common chemotherapies. The invention could lead to better cancer drugs or improvements in the potency of existing ones.
Located in News
Solving Cancer’s Secrets: 5 Questions with Dr. Chuck Perou
Five questions for Chuck Perou, PhD, a UNC geneticist on the hunt for better treatments for the most deadly form of breast cancer
Located in News
Rebecca Fry
Rebecca Fry, PhD, is a UNC Lineberger Comprehensive Cancer Center member and Assistant Professor of Environmental Sciences & Engineering at UNC-Chapel Hill Gillings School of Global Public Health.
Located in People
Cyrus Vaziri
PhD, Pathology & Lab Medicine, UNC-Chapel Hill, Cancer Genetics
Located in People
UNC Lineberger sequences 10,000 tumors as part of national cancer genomics effort
UNC sequenced the RNA for 10,000 tumor samples as part of The Cancer Genome Atlas project, a National Cancer Institute and National Human Genome Research Institute-backed effort to create a comprehensive atlas of the genetic changes in cancer.
Located in News
Cancer genetics the focus of UNC Lineberger symposium
UNC Lineberger's 39th annual scientific symposium was held April 8-9 at the William and Ida Friday Center for Continuing Education in Chapel Hill.
Located in News
UNC scientists funded to study genome sequencing in clinical settings
Chapel Hill - The complete sequence of an individual’s genome – all 3 billion DNA building blocks - will soon be affordably available to doctors, patients and even consumers. While knowledge of one’s genome may have important medical benefits, tremendous questions remain regarding an avalanche of such data means and how they should be used. Many clinical, ethical and social issues arise from the evaluation, use and sharing of the data.
Located in News / 2011 News
Joel Parker
PhD, School of Medicine, UNC-Chapel Hill, Cancer Genetics
Located in People
Dale Ramsden
PhD, Biochemistry and Biophysics , UNC-Chapel Hill, Cancer Genetics
Located in People